CANCER 2026 Steven Ngo
Francis Crick Institute, LONDON, United Kingdom
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Venetoclax and azacitidine induced damage to the bone marrow vasculature significantly impacts engraftment of highly primitive donor derived haematopoietic stem cells. (131759)
10:15 AM
Steven Ngo
Session 3: Immune evasion and cancer immunotherapy
Targeting macrophage-specific vulnerabilities to reduce relapse following AML differentiation therapy. (#265)
5:35 PM
Jake H Tremewen
Poster Session 2